[{"id":"VR218022_rubric_category_0","type":"custom","title":"FRQ Score","stimulusHtml":"<p>Select a point value to view scoring criteria and/or examples, and to score the response.</p><p><strong>General Considerations</strong></p><p>For Task A1, the response must describe the executive branch authority used by the FDA in reclassifying insulin as a biologic.</p><p>For Task A2, the response must explain how the use of the FDA’s authority might affect the success of the Biologics Price Competition and Innovation Act.</p><p>For Task B, the response must explain how Congress could have addressed the increasing cost of insulin prior to 2017.</p><p>For Task C1, the response must describe an informal power the president could use to influence the FDA’s decision to reclassify insulin as a biologic.</p><p>For Task C2, the response must explain how the use of that informal power relates to the principle of separation of powers.</p>","labels":["0 points","1 point","2 points","3 points","4 points","5 points"],"values":[0,1,2,3,4,5],"maxScores":[5,5,5,5,5,5],"descriptions":["<p>The response accomplishes <strong>none</strong> of the tasks set by the question.</p>","<p>The response accomplishes any <strong>one</strong> of the tasks set by the question.</p>","<p>The response accomplishes any <strong>two</strong> of the tasks set by the question.</p>","<p>The response accomplishes any <strong>three</strong> of the tasks set by the question.</p>","<p>The response accomplishes any <strong>four</strong> of the tasks set by the question.</p>","<p>The response accomplishes any <strong>five</strong> of the tasks set by the question.</p>"]}]